TCR2 Therapeutics Files for IPO
Immunotherapy company TCR2 Therapeutics has filed with the SEC regarding its initial public offering.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 112Opko Settles Fraud Charges With SEC: Good News for Investors?
Opko Health shares shot up on Friday after the firm announced that it has settled with the SEC with regard to charges against the company's CEO.
Harpoon Therapeutics Files for IPO
Clinical-stage immunotherapy company Harpoon Therapeutics has filed with the SEC for its initial public offering.
Is Spectrum Pharma’s FDA Update Good News for Breast Cancer Patients?
Spectrum Pharma shares dipped on Thursday after the firm announced a key update from the FDA on its treatment of neutropenia in breast cancer patients.
Short Sellers Hike Bets in Major Pharma Stocks
The December 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Short Sellers Can’t Make Up Their Minds on Major Biotechs
The December 14 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Hemp May Be Legal Now, but Products Still Need to Jump Through FDA Hoops
Although hemp has been removed from the FDA's list of controlled substances, the agency retains authority to review for safety products that use hemp.
Private Equity Firm Pays $1.9 Billion for Mindbody
Vista Equity Partners has agreed to acquire health and wellness software platform provide Mindbody for $1.9 billion in cash. The price represents a premium of 68% to Friday's closing price.
Gritstone Oncology Receives Key FDA Update
Gritstone shares made a handy gain on Friday after the firm received a key update from the FDA.
Eli Lilly Receives Crucial FDA Update on Lupus Study
Eli Lilly shares rose slightly on Thursday after the company announced an FDA update on its treatment for systemic lupus erythematosus.
Johnson & Johnson Under Fire After Claims of Asbestos in Baby Powder
Johnson & Johnson shares dropped on Friday after it came public that the company knew for decades that its baby powder sometimes contained the known carcinogen asbestos.
Meet Thursday’s Biggest Biotech Movers
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Meet Pfizer and GlaxoSmithKline’s New Joint Venture
GlaxoSmithKline shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer. These two firms will create a premier global consumer health care company combining their robust iconic brands.
Why Tilray Is Booming
Tilray shares made a solid gain on Tuesday after the company announced that it entered a global agreement to collaborate with Sandoz, a subsidiary of Novartis.
Credit Suisse 2019 Medical Devices Outlook Looks Very Bullish, Even Out to 2025
A Credit Suisse analyst issued a broad new sector coverage for medical devices and related companies with strong Outperform ratings on Tuesday.